Artwork

Innhold levert av Dr Jedha. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Dr Jedha eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Unspoken Truths About Prescription Medication with Suzanne Robotti

25:00
 
Del
 

Manage episode 407687380 series 3526937
Innhold levert av Dr Jedha. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Dr Jedha eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Discover the untold truths of medication safety as we hear from special guest Suzanne Robotti from MedShadow in this third installment of the ‘Medication March’ series.
We explore the often-hidden complexities that come with newly approved drugs and Su’s experience on an FDA advisory committee approving the drug Wogovy for diabetes. We discuss prioritizing safety and advocacy in the realm of medication. Su sheds light on a startling statistic: a considerable proportion of newly approved drugs come with concerning health warnings several years post-approval.
We delve in to address the concerning trend of overprescription and the potential toxic effects of diabetes medications. Importantly, we encourage you to take charge of your health and not shy away from probing your doctor or healthcare team about the necessity and risks of prescribed medications.
It’s up to you to be the boss of your own medicines, and we share ways in which you can do that!
This series is all about ensuring:
>> You realize you’re not alone in the challenges you may face with healthcare professionals and the healthcare system.
>> You have the information and knowledge about diabetes medications that you need to make informed decisions.
>> You know how to have meaningful dialogue with your doctor to foster a collaborative relationship that actually leads to better health outcomes for you.
>> You become your own best advocate and take charge of your diabetes health.
Please get involved in this conversation!
Visit Type2DiabetesTalk.com and leave your comments on any of the Medication March episodes, or leave us a voice message or send an email with your questions and experiences.
CHAPTERS

2:37 Surprising Medication Facts

4:41 Federal Drug Administration Approvals

8:02 Conflicts of Interest

15:59 Medication Risks and Diabetes Reduction

20:08 Taking Charge of Your Own Health
For show notes and resources, please visit: https://Type2DiabetesTalk.com
To share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/message
Explore our proven programs and services, visit: https://Type2DiabetesTalk.com/programs
Subscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe

  continue reading

24 episoder

Artwork
iconDel
 
Manage episode 407687380 series 3526937
Innhold levert av Dr Jedha. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Dr Jedha eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Discover the untold truths of medication safety as we hear from special guest Suzanne Robotti from MedShadow in this third installment of the ‘Medication March’ series.
We explore the often-hidden complexities that come with newly approved drugs and Su’s experience on an FDA advisory committee approving the drug Wogovy for diabetes. We discuss prioritizing safety and advocacy in the realm of medication. Su sheds light on a startling statistic: a considerable proportion of newly approved drugs come with concerning health warnings several years post-approval.
We delve in to address the concerning trend of overprescription and the potential toxic effects of diabetes medications. Importantly, we encourage you to take charge of your health and not shy away from probing your doctor or healthcare team about the necessity and risks of prescribed medications.
It’s up to you to be the boss of your own medicines, and we share ways in which you can do that!
This series is all about ensuring:
>> You realize you’re not alone in the challenges you may face with healthcare professionals and the healthcare system.
>> You have the information and knowledge about diabetes medications that you need to make informed decisions.
>> You know how to have meaningful dialogue with your doctor to foster a collaborative relationship that actually leads to better health outcomes for you.
>> You become your own best advocate and take charge of your diabetes health.
Please get involved in this conversation!
Visit Type2DiabetesTalk.com and leave your comments on any of the Medication March episodes, or leave us a voice message or send an email with your questions and experiences.
CHAPTERS

2:37 Surprising Medication Facts

4:41 Federal Drug Administration Approvals

8:02 Conflicts of Interest

15:59 Medication Risks and Diabetes Reduction

20:08 Taking Charge of Your Own Health
For show notes and resources, please visit: https://Type2DiabetesTalk.com
To share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/message
Explore our proven programs and services, visit: https://Type2DiabetesTalk.com/programs
Subscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe

  continue reading

24 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett